Fish Oil for Secondary Prevention of Atrial Fibrillation: Should We Still Believe in Its Antiarrhythmic Effect?

Circulation - United States
doi 10.1161/circulationaha.111.048140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Statins in Secondary Prevention of Atrial Fibrillation

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2016English

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Whom Should We Believe?

Chemical and Engineering News
Chemical Engineering
1975English

We Can Prevent Post-Esophagectomy Atrial Fibrillation, but Should We?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

The Role of MicroRNAs in Antiarrhythmic Therapy for Atrial Fibrillation

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2015English

Fish Oil and Sepsis: We Still Need More Trials

Critical Care
Critical CareIntensive Care Medicine
2011English

Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation

American Heart Journal
Cardiovascular MedicineCardiology
2013English

Risk Factors Modification for Primary and Secondary Prevention of Atrial Fibrillation – Part II

Kardiologia Polska
Cardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy